Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.
HALO
$100.27
-0.40%
HALO
· Halozyme Therapeutics, Inc.
$100.27
-0.40 (-0.40%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$11.43B
Shares
114.01M
Volume · Nov 13
2.28M
Avg daily vol (3M)
2.24M
All webcasts
Earnings call · FY2019 Q4
Halozyme Therapeutics, Inc. (HALO) Q4 2019 Earnings Call
Revenue
$53.66M
-10.9% YoY
Diluted EPS
-$0.24
Gross margin
11.2%
+2.8 pp YoY
Net income
-$34.40M
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Feb 24, 2020 · complete as-filed document
SEC periodic report
10-K report
Filed Feb 24, 2020 · complete as-filed document